Viewing xxx of yyy chapters [show all][condense]
- Background
- Grading of Clinical Practice Recommendations
- Clinical Practice Recommendations and Practice Points
- Summary of Evidence - Methodology
- Summary of Evidence - Introduction
- Summary of Evidence - Vasomotor symptoms
- Summary of Evidence - Sleep disturbance
- Summary of Evidence - Vulvovaginal symptoms and sexual function
- Summary of Evidence - Depression and anxiety
- Summary of Evidence - Mood and emotional wellbeing
- Summary of Evidence - Mental health
- Summary of Evidence - Global quality of life
- Summary of Evidence - Breast cancer recurrence
- Strengths and Weaknesses of the Evidence
- Unanswered Questions Regarding Treatments of Interest
- International Guidelines
- Ongoing and Additional Trials of Interest
- Drug Contraindications and Side Effects
- Evidence Matrix
- References
- Acknowledgements
- Additional Information
- Appendix 1: Grading Methodology
- Appendix 2: Evidence Summaries
- Appendix 3: Recommendation Grading Forms
Eleven international guidelines that included recommendations relevant to the treatment of menopausal symptoms in women who have been treated for breast cancer were identified during the literature search for this guideline. Details of all relevant recommendations made by others are provided in the Cancer Australia Primary Systematic Review, Appendix H.